Methyl Alcohol

Methyl Alcohol

SCHEMBL4591601

CC1(C)OCCO1.CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932700 0.92
SCHEMBL85991 0.92
SCHEMBL27942585 0.88
Potassium SCHEMBL30087616 0.88
Methylamine SCHEMBL27082389 0.85
SCHEMBL14320818 0.81 TTR (0.43)
SCHEMBL10187695 0.77
SCHEMBL1060050 0.77
SCHEMBL326285 0.77
Tetrahydrofuran SCHEMBL10705246 0.76 ALDH1A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023247725-A1 PROCESS FOR PREPARING SOLKETAL ACRYLATE BY TRANSESTERIFICATION BASF SE (DE) 2023-12-28 WO disclosed
US-20230330047-A1 DISPERSIBLE FORMULATIONS OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2- FLUORO-4-IODO-PHENYLAMINO)-BENAZMIDE AND USES THEREOF SPRINGWORKS THERAPEUTICS, INC. (US) 2023-10-19 US disclosed
EP-3603398-A1 AGROCHEMICAL COMPOSITION AND METHODS OF PREPARING AND USING THE SAME RHODIA OPERATIONS (FR) 2020-02-05 EP disclosed
EP-1556078-A4 METHODS FOR TREATING LUNG CANCER USING INSULIN-LIKE GROWTH FACTORBINDING PROTEIN-3 INSMED INC (US) 2008-01-09 EP disclosed
EP-1556078-A1 METHODS FOR TREATING LUNG CANCER USING INSULIN-LIKE GROWTH FACTORBINDING PROTEIN-3 Insmed, Inc. (US) 2005-07-27 EP disclosed
US-20040127411-A1 Methods for treating lung cancer using insulin-like growth factor binding protein-3 INSMED, INC. 2004-07-01 US disclosed
WO-2004024179-A1 METHODS FOR TREATING LUNG CANCER USING INSULIN-LIKE GROWTH FACTORBINDING PROTEIN-3 INSMED, INC. (US) 2004-03-25 WO disclosed